Molecular and cellular basis of the retrovirus resistance in I/LnJ mice

Journal of Immunology

Volumn 175, Issue 11, 2005, Pages 7543-7549

  Case, Laure K ^a   Purdy, Alexandra ^a   Golovkina, Tatyana V ^a,b  

^a JACKSON LABORATORY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROGENY; RECEPTOR BINDING; RETROVIRUS; VIRION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 28244436490     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.11.7543     Document Type: Article

References (55)

1. Goff, S. P. 2001. Retroviruses and their replication. In Fundamental Virology, 4th Ed. D. M. Knipe and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, pp. 843-912.
2. Beutner, U., E. Kraus, D. Kitamura, K. Rajewsky, and B. T. Huber. 1994. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179: 1457-1466.
3. Golovkina, T. V., M. Shlomchik, L. Hannum, and A. Chervonsky. 1999. Organogenic role of B lymphocytes in mucosal immunity. Science 286: 1965-1968.
4. Choi, Y., J. W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of the mouse mammary tumor virus. Nature 350: 203-207.
5. Chervonsky, A. V., J. Xu, A. K. Barlow, M. Khery, R. A. Flavell, and C. Janeway, Jr. 1995. Direct physical interaction involving CD40 ligand on T cells and CD40 on B cells is required to propagate MMTV. Immunity 3: 139-146.
6. Held, W., G. Waanders, A. N. Shakhov, L. Scarpellino, H. Acha-Orbea, and H. R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74: 529-540.
7. Varmus, H. E., T. Padgett, S. Heasley, G. Simon, and J. M. Bishop. 1977. Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA. Cell 11: 307-319.
8. Peters, G, 1990. Oncogenes at viral integration sites. Cell Growth Differ. 1: 503-510.
9. Marrack, P., E. Kushnir, and J, Kappler. 1991. A maternally inherited superantigen encoded by mammary tumor virus. Nature 349: 524-526.
10. Coffin, J. M. 1996. Retroviridae: the viruses and their replication. In Fundamental Virology, 3rd Ed. B. N. Fields, P. M. Howley, and D. M. Knipe, eds. Raven Press, New York, pp. 763-844.
11. Acha Orbea, H., A. N. Shakhov, L. Scarpellino, E. Kolb, V. Muller. A. Vessaz Shaw, R. Fuchs, K. Blochlinger, P. Rollini, J. Billotte, et al. 1991. Clonal deletion of Vβ14-bearing T cells in mice transgenic for mammary tumor virus. Nature 350: 207-211.
12. Golovkina, T. V., A. V. Chervonsky, J. P. Dudley, and S. R. Ross. 1992. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69: 637-645.
13. Begovich, A. B., T. H. Vu, and P. P. Jones. 1990. Characterization of the molecular defects in the mouse Ebf and Ebq genes: implication for the origin of MHC polimorphism. J. Immunol. 144: 1957.
14. Dembic, Z., M. Ayane, J. Klein, M. Steinmetz, C. O. Benoist, and D. J. Mathis. 1985. Inbred and wild mice carry identical deletions in their Eα MHC genes. EMBO J. 4: 127.
15. Muhlbock, O., and A. Dux. 1981. Histocompatibility Genes and Mammary Cancer. Elsevier/North-Holland Biomedical Press, Amsterdam.
16. Purdy, A., L. Case, M. Duvall, M. Overstrom-Coleman, N. Monnier, A. Chervonsky, and T, Golovkina, 2003. Unique resistance of I/LnJ mice to a retrovirus is due to sustained Interferon γ-dependent production of virus-neutralizing antibodies. J. Exp. Med. 197: 233-243.
17. Golovkina, T. V., I, Piazzon, I. Nepomnaschy, V. Buggiano, M. de Olano Vela, and S. R. Ross. 1997. Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses. J. Virol. 71: 3895-3903.
18. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350: 423-426.
19. + cells but markedly decreased helper cell activity in mice lacking CD4. Nature 353: 180-184.
20. Fung-Leung, W. P., M. W. Schilham, A. Rahemtulla, T. M. Kundig, M. Vollenweider, J. Potter, W. van Ewijk, and T. W. Mak. 1991. CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65: 443-449.
21. Golovkina, T. V., A. Jaffe, and S. R. Ross. 1994, Coexpression of exogenous and endogenous mouse-mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range. J. Virol 68: 5019-5026.
22. Bechtold, L. 2000. Systematic approach to evaluation of mouse mutations. In Ultrastructural Evaluation of Mouse Mutations, J. P. Sundberg, ed. CRC Press, Boca Raton, pp. 121-129.
23. Jude, B. A., Y. Pobezinskaya, J. Bishop, S. Parke, R. M. Medzhitov, A. V. Chervonsky, and T. V. Golovkina. 2003. Subversion of the innate immune system by a retrovirus. Nat. Immunol. 4: 573-578.
24. Golovkina, T. V. 2000. A novel mechanism of resistance to mouse mammary tumor virus infection. J. Virol. 74: 2752-279.
25. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259: 1739-1742.
26. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-γ receptor. Science 259: 1742-1745.
27. Schijns, V. E., B. L. Haagmans, E. O. Rijke, S. Huang, M. Aguet, and M. C. Horzinek. 1994. IFN-γ receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses. J. Immunol. 153: 2029-2037.
28. Graham, M. B., D. K. Dalton, D. Giltinan, V. L. Braciale, T. A. Stewart, and T. J. Braciale. 1993. Response to influenza infection in mice with a targeted disruption in the Interferon γ gene. J. Exp. Med. 178: 1725-1732.
29. Coulie, P. G., and J. Van Snick. 1985. Enhancement of IgG anti-carrier responses by IgG2 anti-hapten antibodies in mice. Eur. J. Immunol 15: 793-798.
30. Heusser, C. H., C. L. Anderson, and H. M. Grey. 1977. Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line. J. Exp. Med. 145: 1316-1327.
31. Klaus, G. G., M. B. Pepys, K. Kitajima, and B. A. Askonas. 1979. Activation of mouse complement by different classes of mouse antibody. Immunology 38: 687-695.
32. Coutelier, J. P., J. T. van der Logt, F. W. Heessen, G. Warmer, and J. Van Snick. 1987. IgG2a restriction of murine antibodies elicited by viral infections. J. Exp. Med. 165: 64-69.
33. Hasenkrug, K. J., A. Valenzuela, V. A. Letts, J. Nishio, B. Chesebro, and W. N. Frankel. 1995. Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. J. Virol. 69: 2617-2620.
34. Chesebro, B., K. Wehrly, M. Cloyd, W. Britt, J. Portis, J. Collins, and J. Nishio. 1981. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: Friend-specific and FMR-specific antigens. Virology 112: 131-144.
35. Ignatowicz, L., J. Kappler, and P. Marrack. 1992. The effects of chronic infection with a superantigen-producing virus. J. Exp. Med. 175: 917-923.
36. Burton, D. R. 1985. Immunoglobulin G: functional sites. Mol. Immunol. 22: 161-206.
37. Casadevall, A., and L. A. Pirofski. 2003. Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends Immunol. 24: 474-478.
38. Golovkina, T., Y. Agafonova, D. Kazansky, and A. Chervonsky. 2001. Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens. J. Immunol. 166: 2244-2250.
39. Held, W., A. N. Shakhov, G. Waanders, L. Scarpellino, R. Luethy, J.-P. Kraehenbuhl, H: R. MacDonald, and H. Acha-Orbea. 1992. An exogenous mouse mammary tumor virus with properties of M1s-1a (Mtv-7). J. Exp. Med. 175: 1623-1633.
40. Piazzon, I., A. Goldman, S. Torello, I. Nepomnaschy, A. Deroche, and G. Dran. 1994, Transmission of an M1s-1a-like superantigen to BALB/c mice by foster-nursing on F1 M1s-1bxa mothers: sex-influenced onset of clonal deletion. J Immunol. 153: 1553-1562.
41. Acha-Orbea, H., D. Finke, A. Attinger, S. Schmid, N. Wehrli, S. Vacheron, I. Xenarios, L. Scarpellino, K. M. Toellner, I. C. MacLennan, and S. A. Luther. 1999. Interplays between mouse mammary tumor virus and the cellular and humoral immune response. Immunol. Rev. 168: 287-303.
42. Rassa, J. C., J. L. Meyers, Y. Zhang, R. Kudaravalli, and S. R. Ross. 2002. Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 99: 2281-2286.
43. Chesebro, B., and K. Wehrly. 1979. Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex. Proc. Natl. Acad. Sci. USA 76: 425-429.
44. Dittmer, U., K. E. Peterson, R. Messer, I. M. Stromnes, B. Race, and K. J. Hasenkrug. 2001. Role of interleukin-4 (IL-4), IL-12, and γ interferon in primary and vaccine-primed immune responses to Friend retrovirus infection. J. Virol. 75: 654-660.
45. Stromnes, I. M., U. Dittmer, T. N. Schumacher, K. Schepers, R. J. Messer, L. H. Evans, K. E. Peterson, B. Race, and K. J. Hasenkrug. 2002. Temporal effects of γ interferon deficiency on the course of Friend retrovirus infection in mice. J. Virol. 76: 2225-2232.
46. + T cells in the Friend murine retrovirus neutralizing antibody response: evidence for functional T cells in genetic low-recovery mice. J. Virol. 72: 9400-9403.
47. Pucillo, C., R. Cepeda, and R. J. Hodes. 1993. Expression of a MHC class II transgene determines both superantigenicity and susceptibility to mammary tumor virus infection. J Exp. Med. 178: 1441-1445.
48. Kostrikis, L. G., Y. Cao, H. Ngai, J. P. Moore, and D. D. Ho. 1996. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J. Virol: 70: 445-458.
49. Moog, C., H. J. Fleury, I. Pellegrin, A. Kirn, and A. M. Aubertin. 1997. Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals. J. Virol. 71: 3734-3741.
50. Richman, D. D., T. Wrin, S. J. Little, and C. J. Petropoulos. 2003. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. USA 100: 4144-4149.
51. Matthews, T. J., A. J. Langlois, W. G. Robey, N. T. Chang, R. C. Gallo, P. J. Fischinger, and D. P. Bolognesi. 1986. Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc. Natl. Acad. Sci. USA 83: 9709-9713.
52. Ochsenbein, A. F., D. D. Pinschewer, S. Sierro, E. Horvath, H. Hengartner, and R. M. Zinkernagel. 2000. Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 97: 13263-13268.
53. Slifka, M. K., R. Antia, J. K. Whitmire, and R. Ahmed. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8: 363-372.
54. Zinkernagel, R. M. 2002, On differences between immunity and immunological memory. Curr. Opin. Immunol. 14: 523-536.
55. McElrath, M. J., L. Corey, D. Momefiori, M. Wolff, D. Schwanz, M. Keefer, R. Belshe, B. S. Graham, T. Matthews, P. Wright, et al. 2000. A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection: AIDS Vaccine Evaluation Group. AIDS Res. Hum. Retroviruses 16: 907-919.